Value of serum human epidermal growth factor receptor 2 (HER2)/neu testing for early prediction of response to HER2/neu-directed therapies is still an open one and deserves further study in large prospective trials.
作者信息
Ali Suhail M, Leitzel Kim, Lipton Allan, Carney Walter P, Köstler Wolfgang J
出版信息
J Clin Oncol. 2009 Dec 20;27(36):e273; author reply e274-5. doi: 10.1200/JCO.2009.23.4674. Epub 2009 Nov 16.